Datapoint: Express Scripts to Offer New “Cost-Plus” Pricing Model
The Cigna Group’s Express Scripts PBM announced on Nov. 14 that it’s launching a new “cost-plus” prescription drug pricing model for its clients. With the Express Scripts ClearNetwork, “clients pay a straight-forward estimated acquisition cost for individual medications, in addition to a small markup for pharmacy dispensing and service costs.” Express Scripts plans on launching the model in early 2024 and applying it toward generic, branded and specialty drugs. Express Scripts currently serves 22.3 million commercial pharmacy lives and 950,000 Medicare pharmacy lives.
SOURCE: MMIT Analytics, as of 11/20/23
© 2024 MMIT